KFDA pushes separation of manufacturing license from product license
Published: 2004-01-12 06:58:00
Updated: 2004-01-12 06:58:00
The Korea Food and Drug Administration said in the 2004 main affairs that it has drafted a revision bill designed to separate the manufacturing license from product license in a bid to help support the industrialization of Korea's biotechnology sector.
The administration said the revision draf...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.